Yangzhou Su
- Cancer Research top 5%
- MicroRNA in disease regulation 1
- Molecular Biology top 10%
- RNA Interference and Gene Delivery 1
- Advanced biosensing and bioanalysis techniques 1
- Extracellular vesicles in disease 1
- Protein Degradation and Inhibitors 1
-
- Immunotherapy and Immune Responses 1
-
- Cancer Immunotherapy and Biomarkers 1
-
- Lung Cancer Treatments and Mutations 1
- Journals
- Science Advances (1 paper)Cancer Immunology Immunotherapy (1 paper)Clinical and Translational Medicine (1 paper)
- Partner nations
- ChinaSaudi ArabiaUnited States
In The Last Decade
Yangzhou Su
4 papers receiving 987 citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Cancer Research 514
- Molecular Biology 861
- Immunology 132
- Oncology 87
- Biomaterials 40
Countries citing papers authored by Yangzhou Su
This map shows the geographic impact of Yangzhou Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangzhou Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangzhou Su more than expected).
Fields of papers citing papers by Yangzhou Su
This network shows the impact of papers produced by Yangzhou Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangzhou Su. The network helps show where Yangzhou Su may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yangzhou Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 93 | |
| 4 | Exosomes: key players in cancer and potential therapeutic strategybreakdown → | 2020 | 899 |
About Yangzhou Su
Yangzhou Su is a scholar working on Otorhinolaryngology, Cancer Research, Immunology, Molecular Biology and Oncology, having authored 4 papers that have together received 994 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (1 paper), Advanced biosensing and bioanalysis techniques (1 paper), Immunotherapy and Immune Responses (1 paper), Extracellular vesicles in disease (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), MicroRNA in disease regulation (1 paper), Protein Degradation and Inhibitors (1 paper) and Lung Cancer Treatments and Mutations (1 paper). The work is most often cited by research in Cancer Research (514 citations), Molecular Biology (861 citations), Immunology (132 citations), Oncology (87 citations) and Biomaterials (40 citations). Yangzhou Su has collaborated with scholars based in China, Saudi Arabia and United States. Frequent co-authors include Suye Zhong, Yongguang Tao, Cong Li, Chao Chen, Junjun Yang, Bang Liu, Yiqun Jiang, Zuping He, Jie Dai and Meiling Zhou. Their work appears in journals such as Science Advances, Cancer Immunology Immunotherapy, Clinical and Translational Medicine and Signal Transduction and Targeted Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.